Yatharth Hospitals isn’t just treating patients – it’s treating investors to a dose of 27% sales growth, ₹926 Cr FY25 revenue, and ₹142 Cr PAT. Occupancy is still at 61%, but the Average Revenue Per Occupied Bed (ARPOB) screams metro premium at ₹30,597. From IPO debt repayment to hospital shopping sprees (Agra, Delhi, Faridabad), Yatharth is expanding faster than your uncle’s cholesterol post-Diwali. At CMP ₹776, the market values it at 52x earnings, which is basically saying – “doctor saab, we trust you more than Apollo’s fees.”
2. Introduction
Let’s be real: private hospitals in India are no longer just about patient care. They’re a business model disguised as “healthcare service.” Yatharth, born in 2008 with trauma care roots, has now grown into a 7-hospital chain with 2,100+ beds across NCR and beyond.
Why the hype?
They cleaned up their balance sheet using IPO money (₹610 Cr raised, debt reduced from ₹264 Cr → ₹11 Cr).
Their Noida cluster has ARPOB of ₹30k+ (basically, one patient = one new iPhone).
They’ve gone full shopping mode: acquired Model Town Delhi (300 beds), Faridabad (400 beds), and now Shantived Hospital Agra (150 beds for ₹260 Cr).
Yet, the expansion binge comes at a cost: high valuations, promoter pledging (13.8%), and the stress of filling shiny new beds in metros already crowded with Apollo, Max, and Fortis.
Question: Is Yatharth a serious contender to NCR’s big boys, or just flexing with borrowed surgical gloves?
3. Business Model – WTF Do They Even Do?
The recipe is simple: buy hospitals, ramp occupancy, charge metro-level fees, and collect the insurance cheques.
Current footprint:
Greater Noida (400 beds) – mid-size but decent occupancy (66%).
Noida (250 beds) – small but star performer with 83% occupancy.
Noida Extension (450 beds) – flagship with robotic surgery toys, 60% occupancy.
Jhansi-Orchha (305 beds) – the “rural cousin” at 47% occupancy and ARPOB of just ₹12k.
Greater Faridabad (200 beds) – occupancy only 28%, basically ICU for investors.
Revenue contribution (H1 FY25):
Noida Extension – 37%
Greater Noida – 32%
Noida – 22%
Jhansi + Faridabad – 9% (token charity case).
Specialties: Oncology (18%), Internal Medicine (12%), Nephrology (12%), Cardiology (11%), and the rest split among neuro, gastro, ortho, gynae, etc.
In short, it’s a desi Max Healthcare wannabe – smaller, cheaper, but learning fast.
Commentary: Growth is impressive, but let’s not forget – occupancy is still just 61%, meaning there’s plenty of slack to sweat assets before further expansion.
